Seliciclib, also known as Roscovitine or CYC202, is a potent and selective inhibitor of cyclin-dependent kinases (CDKs) that has garnered significant attention in cancer research. As a pharmaceutical intermediate and a valuable research chemical, understanding its mechanisms of action is crucial for scientists exploring new therapeutic strategies. This molecule, with CAS number 186692-46-6, offers researchers a powerful tool to investigate cell cycle regulation and its dysregulation in cancerous cells.

CDKs are critical regulators of the cell cycle, controlling progression through different phases. In many cancers, these kinases are overactive, leading to uncontrolled cell proliferation. Seliciclib targets key CDKs, including CDK1, CDK2, CDK5, CDK7, CDK9, and CDK12, effectively halting the cell cycle and preventing tumor growth. Its ability to induce cell cycle arrest at the G1 and G2/M phases makes it a compelling candidate for drug development.

Beyond cell cycle arrest, Seliciclib is also known to induce apoptosis, or programmed cell death, in various cancer cell lines. This dual action – inhibiting proliferation and triggering cell death – underscores its therapeutic potential. Scientists often use Seliciclib in preclinical studies to evaluate its efficacy against specific cancer types, such as B-cell lymphoma, breast cancer, and lung cancer. The search for high-quality Seliciclib for these investigations is ongoing, with many researchers looking to established manufacturers and suppliers.

For researchers needing to purchase Seliciclib, sourcing from reputable Chinese manufacturers can provide access to high-purity material at competitive prices. When procuring this vital compound, it's important to verify purity levels (typically >98% by HPLC) and ensure that the supplier can provide detailed technical specifications and support. Reliable suppliers often offer essential information on storage conditions and handling, which are crucial for maintaining the compound's integrity.

In essence, Seliciclib is an indispensable research chemical for scientists delving into cancer biology and the development of targeted therapies. Its well-documented CDK inhibitory and pro-apoptotic activities continue to fuel innovation in the field. Researchers can buy Seliciclib with confidence from dedicated suppliers who prioritize quality and consistency, thereby advancing their critical work in the fight against cancer.